I am a science and technology journalist who writes about how biology is shaping our future. Currently, I am a staff writer for Medium's OneZero and an adjunct instructor in the graduate science writing program at Johns Hopkins. I write about topics like CRISPR, genetic privacy, reproductive technology, neuroscience, and the field of anti-aging. In my work, I seek to illuminate the both the tremendous benefits and unintended consequences of scientific advances. ​ 


Previously, I served as associate editor for biomedicine at MIT Technology Review. ​There, my enterprise reporting uncovered original stories about a fertility startup advertising an unproven "three-parent" IVF technique, a dubious CRISPR trial in Mexico to treat lung cancer patients, and the first commercial use of a landmark gene therapy a year after its approval. While at Tech Review, I won a Newsbrief Award from the D.C. Science Writers Association for my story about a menstrual cycle-on-a-chip.

​My stories have been published by The Washington Post, New York Times, Wall Street Journal, Scientific American, National Geographic, The Atlantic, Science, Quartz, Pacific Standard, and The Baltimore Sun, among others. I've also been a contributor at Forbes


I started my career as a reporter at the Baltimore Business Journal, where I followed the high-profile case of a Maryland cardiologist accused of implanting unnecessary heart stents in patients. I earned my bachelor's degree in journalism at Ohio University and a master's in science writing from Johns Hopkins. I hail from the scenic Laurel Highlands of Western Pennsylvania and now live in Baltimore, Maryland.


© 2019 Emily Mullin

  • Grey Twitter Icon
  • Grey LinkedIn Icon